Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masayuki Sugiki is active.

Publication


Featured researches published by Masayuki Sugiki.


ACS Medicinal Chemistry Letters | 2016

Interaction Analysis of FABP4 Inhibitors by X-ray Crystallography and Fragment Molecular Orbital Analysis

Uno Tagami; Kazutoshi Takahashi; Shunsuke Igarashi; Chieko Ejima; Tomomi Yoshida; Sen Takeshita; Wataru Miyanaga; Masayuki Sugiki; Munetaka Tokumasu; Toshihiro Hatanaka; Tatsuki Kashiwagi; Kohki Ishikawa; Hiroshi Miyano; Toshimi Mizukoshi

X-ray crystal structural determination of FABP4 in complex with four inhibitors revealed the complex binding modes, and the resulting observations led to improvement of the inhibitory potency of FABP4 inhibitors. However, the detailed structure-activity relationship (SAR) could not be explained from these structural observations. For a more detailed understanding of the interactions between FABP4 and inhibitors, fragment molecular orbital analyses were performed. These analyses revealed that the total interfragment interaction energies of FABP4 and each inhibitor correlated with the ranking of the K i value for the four inhibitors. Furthermore, interactions between each inhibitor and amino acid residues in FABP4 were identified. The oxygen atom of Lys58 in FABP4 was found to be very important for strong interactions with FABP4. These results might provide useful information for the development of novel potent FABP4 inhibitors.


Journal of Biochemistry | 2018

Protein engineering for improving the thermostability of tryptophan oxidase and insights from structural analysis

Hiroki Yamaguchi; Moemi Tatsumi; Kazutoshi Takahashi; Uno Tagami; Masayuki Sugiki; Tatsuki Kashiwagi; Masafumi Kameya; Seiji Okazaki; Toshimi Mizukoshi; Yasuhisa Asano

l-Tryptophan oxidase, VioA from Chromobacterium violaceum, which has a high substrate specificity for tryptophan, is useful for quantitative assay of tryptophan. However, stability of wild type VioA is not enough for its application in clinical or industrial use. To improve the thermal stability of the enzyme, we developed a VioA (C395A) mutant, with higher stability than wild type VioA. The VioA (C395A) exhibited similar specificity and kinetic parameter for tryptophan to wild type. Conventionally, the quantity of tryptophan is determined by instrumental methods, such as high-performance liquid chromatography (HPLC) after pre-column-derivatization. Using the mutant enzyme, we succeeded in the tryptophan quantification in human plasma samples, to an accuracy of <2.9% when compared to the instrumental method, and to a precision of CV <3.2%. To analyse the improvement in storage stability and substrate specificity, we further determined the crystal structures of VioA (C395A) complexed with FAD, and with FAD and tryptophan at 1.8 Å resolution.


Archive | 2001

Novel phenylalanine derivatives

Kazuyuki Sagi; Tatsuya Okuzumi; Tatsuhiro Yamada; Shunsuke Kageyama; Yoichiro Shima; Tadakiyo Nakagawa; Munetaka Tokumasu; Masayuki Sugiki; Hajime Ito; Itsuya Tanabe; Tamotsu Suzuki; Akira Nakayama; Kazuyuki Ubukata; Kenji Shinkai; Yasuhiro Tanaka; Misato Noguchi; Ayatoshi Andou; Yoriko Yamamoto; Noriyasu Kataoka; Koichi Fujita


Bioorganic & Medicinal Chemistry | 2005

Optimization of a coagulation factor VIIa inhibitor found in factor Xa inhibitor library.

Kazuyuki Sagi; Koichi Fujita; Masayuki Sugiki; Mitsuo Takahashi; Shunji Takehana; Kazumi Tashiro; Takashi Kayahara; Masahiro Yamanashi; Yumiko Fukuda; Seiji Oono; Akiko Okajima; Seinosuke Iwata; Masataka Shoji; Kuniya Sakurai


Archive | 2008

POLY(AMINO ACID) COMPOUND HAVING INHIBITORY ACTIVITY ON ABSORPTION OF PHOSPHORUS AND PHOSPHORUS ABSORPTION INHIBITOR

Tadakiyo Nakagawa; Hironobu Tsugeno; Naomi Matsutani; Masayuki Sugiki; Haruko Hirashima; Tatsuya Okuzumi; Tatsuya Kasahara; Wataru Miyanaga; Takashi Yamamoto; Masatsugu Noguchi; Kayo Matsumoto; Hideyuki Tanaka; Tomoyuki Konda


Archive | 2011

METHOD FOR PREPARING PHENYLALANINE DERIVATIVES HAVING QUINAZOLINE-DIONE SKELETON AND INTERMEDIATES FOR USE IN THE PREPARATION OF THE DERIVATIVES

Noriyasu Kataoka; Kotaro Okado; Tatsuhiro Yamada; Koichi Fujita; Tamotsu Suzuki; Tatsuya Okuzumi; Masayuki Sugiki; Akinori Tatara


Archive | 2013

Sulfonamide derivative and medicinal use thereof

Hirokazu Ueno; Takashi Yamamoto; Ryuta Takashita; Ryohei Yokoyama; Toshihiko Sugiura; Shunsuke Kageyama; Ayatoshi Ando; Hiroyuki Eda; Agung Eviryanti; Tomoko Miyazawa; Aya Kirihara; Itsuya Tanabe; Tarou Nakamura; Misato Noguchi; Manami Shuto; Masayuki Sugiki; Mizuki Dohi


Archive | 2016

HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME

Kaori Kobayashi; Tamotsu Suzuki; Mizuki Kawahira; Tomohiro Fujii; Masayuki Sugiki; Koji Ohsumi; Tatsuya Okuzumi


Archive | 2000

Amidinophenylpyruvic acid derivatives

Masayuki Sugiki; Kazuyuki Sagi; Kohichi Fujita; Takashi Kayahara; Shunji Takehana; Kuniya Sakurai; Kazumi Tashiro


Archive | 2007

PROCESS FOR PRODUCTION OF PHENYLALANINE DERIVATIVES HAVING QUINAZOLINEDIONE SKELETONS AND INTERMEDIATES FOR THE PRODUCTION

Noriyasu Kataoka; Kotaro Okado; Tatsuhiro Yamada; Koichi Fujita; Tamotsu Suzuki; Tatsuya Okuzumi; Masayuki Sugiki; Akinori Tatara

Collaboration


Dive into the Masayuki Sugiki's collaboration.

Researchain Logo
Decentralizing Knowledge